Table 2. . Overall, 3– and 5-year survival after hepatectomy for breast cancer liver metastases.

Author	Median survival (months)	3-year survival (%)	5-year survival (%)	Ref.
Raab et al.	27	50	18.4	[28]
Selzner et al.	24	35	22 (17% disease free)	[6]
Yashimoto et al.	34	71 (2 years survival)	27	[7]
Pocard et al.	42	65	NR	[15]
Makson et al.	NR	NR	51 (estimated)	[26]
Elias et al.	34	50	34	[19]
Ercolani et al.	40.3	53.9	24.6	[14]
Vlastos et al.	63	86 (2 years survival)	61	[20]
Adam et al.	32 (46 from the date of liver metastasis diagnosis)	NR	37% (41% from the date of liver metastases diagnosis)	[4]
Adam et al.	45	NR	41	[9]
Sakamoto et al.	36	52	21	[24]
Lubrano et al.	42	61	33	[23]
Thelen et al.	NR	50	42	[25]
Bockhorn et al.	NR	53	44
Caralt et al.	35.9	79	33	[16]
Belda et al.	33.8	NR	23	[29]
Hofmann et al.	58	68	48	[9]
Van Walsum et al.	55	WR	37	[12]
Abbott et al.	57	NR	NR	[27]
Dittmar et al.	36	NR	28	[22]
Kostov et al.	43	64.1	38.5	[11]
Ehrl et al.	29	31	20,7	[13]
Bacalbasa et al.	32.2	74.42	58.14	[30]

NR: Not recorded; WR: Wedge resection.